HSBC profit rises while U.S. business deteriorates
Middle East North Africa - Financial Network

Demand More is a registered trade mark of MENAFN.COM

 
GFT_leader_Feb1
 
  Quotes: US MENA   Enter Symbol: NewsLetter: Search News: advanced
 Home  |  MENAFN News  |  Global News RELATED: Global News Regional News News Search

HSBC profit rises while U.S. business deteriorates  Join our daily free Newsletter

MarketWatch.com-Monday, November 10, 2008
Digg This Article: HSBC profit rises while U.S. business deteriorates Share This Article: HSBC profit rises while U.S. business deteriorates Add to Delicious Seed this article Buzz this article Add to Reddit Add to furl Add to stumbleupon Add to Mixx!

HSBC profit rises as U.S. loan losses deteriorate

Bank reclassifies $13 billion of assets, gains $2.4 billion on French asset sale

Last Update: 4:46 AM ET Nov 10, 2008

LONDON (MarketWatch) -- HSBC Holdings said Monday that its third-quarter pretax profit rose from a year earlier after it reclassified $13 billion of assets and generated gains from the changing value of its own debt.

The bank added, however, that its U.S. operations had "declined markedly," due to rising loan impairment charges and further write-downs in its global banking and markets division.

Like several European rivals, HSBC HBC said it had reclassified some trading assets as loans, meaning it didn't have to revalue the assets at market-price, which avoided an $835 million hit to pretax profit in the quarter.

It also benefited from a $2.4 billion gain on the sale of its French regional banking network and $3.4 billion from the changing market value of its own debt -- an accounting effect that will fully reverse as the debt matures.

The bank doesn't reveal profit figures on a quarterly basis, but it said its Asian operations "remained at the heart of core operating profitability."

Shares in the group slipped 0.9% shortly after the announcement, underperforming compared to a 3% rise in the FTSE 100 index. The bank has been one of the most resilient in the credit crisis, with its shares declining 12% since the start of the year.

Loan impairments in U.S. personal financial services -- the worst-hit part of the business -- were $4.3 billion in the quarter, up around $700 million from the second quarter of the year due to higher provisions in both real estate and credit card portfolios.

The bank took a write-down of $600 million on its credit trading position in the quarter.

It also wrote down $4.8 billion on asset-backed securities as the forced sale of assets by other firms pushed market prices down. But this write-down will hit reserves, rather than the bottom line.

The bank said its private banking arm continued to attract funds from wealthy clients, with net new money of $15.6 billion in the quarter and a record month in September. But much of the new money is being kept in cash or government bonds, limiting the bank's ability to profit from the inflows.

The bank's Tier 1 capital ratio stood at 8.9% at the end of the quarter. Several U.K. banks have had to tap the British government for capital in recent weeks. But, like emerging markets-focused rival Standard Chartered , HSBC been able to maintain its capital strength through its strength in Asia.

"Without doubt, global economic growth will continue to slow during the next few quarters as recession takes hold in several mature economies," the bank said in its outlook.

"We expect Asian growth to remain relatively more resilient although it is not yet apparent to what extent governments will succeed in encouraging stronger domestic demand to counterbalance export weakness," it added.



International Provider
Feb 09, 2010 Democratic AGs defend proposed consumer agency, MarketWatch.com
Four Democratic Attorneys General speak in favor of the creation of an independent consumer protection agency for mortgage and credit card products, arguing that federal bank regulators have been an abysmal failure at protecting consumers.
Feb 09, 2010 U.S. stocks pick up steam; Dow rises triple-digits, MarketWatch.com
U.S. stocks rally sharply Tuesday, with the Dow industrials average adding more than 230 points at one point, after a report suggesting a German government bailout of Greece clipped fears of another global financial crisis, and battered the U.S. dollar.
Feb 09, 2010 Hartford drops on concern about TARP repayment, MarketWatch.com
SAN FRANCISCO (MarketWatch) -- Hartford Financial Services Group shares fell more than 5% Tuesday on concern the insurer may have to raise roughly $2 billion in new equity to repay money it got from the U.S. government's Troubled Asset Relief Program, or TARP.
Feb 09, 2010 Tuesday's biggest gaining and declining stocks, MarketWatch.com
Stocks seeing big moves in trading include AMR, Cerus and Electronic Arts.
Feb 09, 2010 Treasurys down after auction, news of Greece plan, MarketWatch.com
Treasury prices decline and yields rise for a second straight session, as investors cheer reports of a European rescue of Greece and the government's auction draws lackluster demand.
Feb 09, 2010 Financials join party as bank gains lift sector, MarketWatch.com
Shares of financial stocks add to earlier gains as banks large and small take a leadership role, with fears of a European debt crisis ebbing and investor sentiment rising in the broader market.
Feb 09, 2010 Dollar drops against euro on news of Greek rescue, MarketWatch.com
The dollar extends losses versus the euro, briefly pushing the shared currency up 1.3%, as speculation mounts over a possible rescue of Greece and other heavily-indebted southern European countries.
Feb 09, 2010 Gold rallies on report of Greek bailout, MarketWatch.com
Gold and metals futures rally, as a report that Germany may rescue Greece from its debts boosts the euro, pressuring the dollar and lifting the price of commodities.
Feb 09, 2010 Updates, advisories and surprises, MarketWatch.com
A roundup of the latest corporate earnings reports and what companies are saying about future quarters.
Feb 09, 2010 Cell Therapeutics, AstraZeneca lead drug stocks, MarketWatch.com
Drug stocks gain while shares of Cell Therapeutics bounce back after diving almost 25% over concerns about its new non-Hodgkin's lymphoma treatment pixantrone.
more...



GFT_Square_Feb1
Google
Terms of Service  |   Privacy Policy  |   Contact Us |   Advertise  |   About MENAFN  |   Career Opportunities  |   Feedback
Copyright ©2000 All Rights Reserved.